John D. Weinberg
Nessuna posizione attualmente
Storia della carriera di John D. Weinberg
Precedenti posizioni note di John D. Weinberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MAAT PHARMA | Direttore Tecnico/Scientifico/R&S | 01/07/2020 | 01/06/2022 |
| VELOXIS PHARMACEUTICALS A/S | Direttore operativo | 01/07/2010 | 29/02/2016 |
| Public Communications Contact | 02/06/2011 | 29/02/2016 | |
| Corporate Officer/Principal | 24/05/2012 | 07/06/2013 | |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
| 4D PHARMA PLC | Direttore Tecnico/Scientifico/R&S | 01/06/2017 | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - | - |
Formazione di John D. Weinberg
| University of the Witwatersrand | Doctorate Degree |
| INSEAD | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Francia | 3 |
| Danimarca | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| MAAT PHARMA | Health Technology |
| Aziende private | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Borsa valori
- Insiders
- John D. Weinberg
- Esperienza
